You are here: Industry Insights > BioNTech

News List

NewsPoints Billionaire’s Bet on Pfizer Vaccine for China Fails to Pay Off FirstWordPharma
December 13, 2021
Beijing is supporting a home-grown mRNA vaccine, allowing China's Walvax Biotechnology Co. to test its own experimental vaccine as a booster, Bloomberg reported.
Pfizer and BioNTech receive expanded U.S. FDA emergency use suthorization of COVID-19 vaccine booster to include individuals 18 and older WorldPharmaNews
November 23, 2021
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine...
Pfizer, BioNTech to supply Covid-19 vaccine paediatric doses to US By PBR Staff Writer Pharmaceutical-Business-Review
November 03, 2021
Pfizer and its partner BioNTech have announced that the US government has purchased additional paediatric doses of their Covid-19 vaccine, as it prepares for paediatric vaccinations.
Pfizer and BioNTech Receive First FDA EUA for COVID-19 Vaccine in Children AmericanPharmaceuticalReview
November 02, 2021
Pfizer and BioNTech announced that the FDA has authorized for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred to as 5 to <12 years).
FDA Approves Comirnaty (Pfizer-BioNTech COVID-19 Vaccine) to Prevent COVID-19 Individuals 16 Years and Older drugs
August 24, 2021
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for Comirnaty (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 16 years.
Pfizer-BioNTech shot becomes first COVID-19 vaccine to gain full FDA approval cphi-online
August 24, 2021
Pfizer and BioNTech’s shot on Monday became the first COVID-19 vaccine to be granted full approval by the US Food and Drug Administration.
Pfizer, BioNTech's COVID-19 vaccine on brink of full FDA approval firstwordpharma
August 23, 2021
According to people familiar with the matter, the FDA is expected to grant full approval to Pfizer and BioNTech's COVID-19 vaccine BNT162b2 as soon as Monday, The New York Times reported.
Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine drugs
August 20, 2021
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that they have submitted Phase 1 data to the U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the companies’ COVID-19 vaccine.
BioNTech says repeats of its COVID-19 vaccine better than devising new one, for now expresspharma
August 11, 2021
The German biotech firm said that offering a third dose of its established two-shot vaccine remained the best response to concerns over waning immune protection in the face of the highly contagious Delta variant, as worse strains may emerge.
BioNTech’s 2Q Revenue Soars contractpharma
August 10, 2021
Growth due to rapid increases in the supply of BNT162b2 as BioNTech and Pfizer evaluate a third dose to boost efficacy against Delta variant.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page